Skip to content

Clinical Comparison of Silicone Hydrogel Monthly Lenses

One-month Clinical Comparison of Silicone Hydrogel Monthly Lenses in High Lipid Depositors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03169153
Enrollment
114
Registered
2017-05-30
Start date
2017-09-22
Completion date
2018-07-19
Last updated
2019-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Keywords

contact lenses, lipids, deposits

Brief summary

The purpose of this study is to compare AIR OPTIX® plus HydraGlyde (AOHG) contact lenses to ACUVUE® VITA® (VITA) contact lenses for total lipid uptake (total of surface and bulk uptake) after 30 days of wear by high lipid depositors.

Interventions

Silicone hydrogel contact lenses used as per their Conformité Européenne (CE) marking

Silicone hydrogel contact lenses used as per their Conformité Européenne (CE) marking

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sign Informed Consent; * Best corrected visual acuity (BCVA) of at least 0.1 logarithm of the minimum angle of resolution (logMAR) in each eye at Visit 1; * Manifest cylinder less than or equal to 0.75 diopter (D) in each eye at Visit 1; * Successful current wearer (during the past 2 months for a minimum of 5 days per week and 8 hours per day) of monthly replacement silicone hydrogel lenses within the power range of lens powers available for the screening and study lenses; * Screening lenses worn 10 hours exhibiting high lipid uptake.

Exclusion criteria

* Habitual lens used in an extended wear modality (routinely sleeping in lenses overnight for 1 night per week or more) during the past 2 months; * Habitually wearing AIR OPTIX AQUA, AIR OPTIX plus HydraGlyde, ACUVUE OASYS®, or ACUVUE VITA as contact lenses during the past 2 months; * Any anterior segment infection, inflammation, disease or abnormality that contraindicates contact lens wear (within 7 days of enrollment, or current) * History of herpetic keratitis, corneal surgery, or irregular cornea; * Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator; * Abnormal ocular conditions or findings, as specified in the protocol; * Known pregnancy and lactation.

Design outcomes

Primary

MeasureTime frameDescription
Mean Ex-vivo Total Lipid Uptake (Total of Surface and Bulk Uptake) Per LensDay 30 after 10 hours of wear, each productContact lens was removed aseptically from the eye. Total lipid (fatty deposits) uptake, defined as total amount of lipids (surface and bulk) absorbed/adsorbed and extracted, was measured in micrograms. A lower value indicates better results. Only one lens from each subject contributed to the analysis.

Countries

United Kingdom

Participant flow

Recruitment details

Subjects were recruited from 1 study center located in the United Kingdom.

Pre-assignment details

Of the 114 enrolled, 29 subjects were exited prior to randomization. An additional 4 subjects discontinued after randomization but prior to exposure. This reporting group includes all randomized and exposed subjects (81).

Participants by arm

ArmCount
Overall
Lotrafilcon B and senofilcon C contact lenses worn during Period 1 and Period 2 in a crossover assignment.
81
Total81

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1, First 30 Days of WearLost to Follow-up11
Period 1, First 30 Days of WearWithdrawal by Subject23
Period 2, Second 30 Days of WearAdverse Event12
Period 2, Second 30 Days of WearCould not attend visit10

Baseline characteristics

CharacteristicOverall
Age, Continuous32.3 years
STANDARD_DEVIATION 9.8
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
60 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 760 / 78
other
Total, other adverse events
0 / 760 / 78
serious
Total, serious adverse events
0 / 760 / 78

Outcome results

Primary

Mean Ex-vivo Total Lipid Uptake (Total of Surface and Bulk Uptake) Per Lens

Contact lens was removed aseptically from the eye. Total lipid (fatty deposits) uptake, defined as total amount of lipids (surface and bulk) absorbed/adsorbed and extracted, was measured in micrograms. A lower value indicates better results. Only one lens from each subject contributed to the analysis.

Time frame: Day 30 after 10 hours of wear, each product

Population: Full Analysis Set with non-missing response

ArmMeasureValue (MEAN)Dispersion
AOHGMean Ex-vivo Total Lipid Uptake (Total of Surface and Bulk Uptake) Per Lens78.1398 micrograms (μg)Standard Deviation 70.7923
VITAMean Ex-vivo Total Lipid Uptake (Total of Surface and Bulk Uptake) Per Lens307.6800 micrograms (μg)Standard Deviation 303.9299
p-value: <0.0001Mixed effects repeated measures

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026